Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: A clinicopathologic study

Archives of Neurology

Volumn 55, Issue 7, 1998, Pages 969-978

  Litvan, I ^a   MacIntyre, A ^a   Goetz, C G ^c   Wenning, G K ^g   Jellinger, K ^d   Verny, M ^j   Bartko, J J ^b   Jankovic, J ^e   McKee, A ^f   Brandel, J P ^j   Ray Chaudhuri, K ^h   Lai, E C ^e   D'Olhaberriague, L ^a   Pearce, R K B ⁱ   Agid, Y ^j  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ Institute of Neurology   (United Kingdom)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOPSY; DEMENTIA; DIAGNOSTIC ACCURACY; HUMAN; LEWY BODY; NEUROPATHOLOGY; PARKINSON DISEASE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RELIABILITY; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; EUROPE; FEMALE; HUMANS; LEWY BODIES; MALE; MIDDLE AGED; PARKINSON DISEASE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 2042468435     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.7.969     Document Type: Article

References (91)

1. McKeithi IG, Galasko D, Kosaka K, el al. Consensus Guidelines International Workshop for the Clinical and Pathological Diagnosis of Dementia With Lewy Bodies (DLB): Report of the Consortium on DLB. Neurology. 1996;47:1113-1124.
2. Calne D. Is "Parkinson's disease" one disease? J Neurol Neurosurg Psychiatry. 1989;52(suppl):18-21.
3. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol. 1990;237:197-204.
4. Katzman R, Galasko D, Saitoh T, Thai LJ, Hansen L. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain Cogn. 1995;28:259-265.
5. Smith MA, Perry G. Is a Lewy body always a Lewy body? In: Korczyn AD, ed. Dementia in Parkinson's Disease. Bologna, Italy: Monduzzi Editore; 1995:187-193.
6. Perry EK, Perry RH, McKeith IG. Is dementia with Lewy bodies a distinct entity [abstract]? Mov Disord. 1996;11(suppl 1):19.
7. Perry G. What exactly is a Lewy body [abstract]? Mov Disord. 1996;11(suppl 1):19.
8. Morris JC, Drazner M, Fulling K, Grant EA, Goldring J. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. Arch Neurol. 1989;46:651-657.
9. Mosla PK, Martila RJ, Rinne UK. Extrapyramidal symptoms in Alzheimer's disease. Neurology. 1984;34:1114-1116.
10. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol. 1993;50:140-148.
11. Mindham RHS, Biggins CA, Boyd JL, et al. A controlled study of dementia in Parkinson's disease over 54 months. Adv Neurol. 1993;60:470-474.
12. Lewy FH. Paralysis agitans, I: pathologische anatomie. In: Lewandowsky M, ed. Handbuch der Neurologie. Vol 3. Berlin, Germany: Julius Springer; 1912:920-933.
13. Tretiakoff C. Contribution a l'etude de l'anatomie pathologique du locus niger de Soemmering [thesis]. Paris, France: Paris University; 1919.
14. Duvoisin R, Golbe L. Toward a definition of Parkinson's disease [letter]. Neurology. 1989;39:746.
15. Forno L. The Lewy body in Parkinson's disease. Adv Neurol. 1986;45:35-43.
16. Gibb WRG. The neuropathology of parkinsonian disorders. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. Baltimore, Md: Urban & Schwarzenberg; 1988:361-376.
17. Jellinger KA, Bancher C. Dementia with Lewy bodies: relationships to Parkinson's and Alzheimer's diseases. In: Perry R, McKeith I, Perry EK, eds. Dementia With Lewy Bodies: Clinical, Pathological and Treatment Issues. New York, NY: Cambridge University Press; 1996:268-286.
18. Jellinger K. Pathology of Parkinson's syndrome. In: Calne DB, ed. Handbook of Experimental Pharmacology. Vol 88. Berlin, Germany: Springer-Verlag; 1989:47-112.
19. Bergeron C, Pollanen M. Lewy bodies in Alzheimer's disease: one or two diseases. Alzheimer Dis Assoc Disord. 1989;3:197-204.
20. Forno LS, Langston JW. Lewy bodies and aging: relation to Alzheimer's and Parkinson's diseases. Neurodegeneration. 1993;2:19-24.
21. Ben-Shlomo Y, Wenning G. Incidental Lewy body disease. Lancet. 1994;344:1503.
22. Woodard JS. Concentric hyaline inclusion body formation in mental disease: analysis of twenty-seven cases. J Neuropathol Exp Neurol. 1962;21:442-449.
23. Tison F, Wenning GK, Daniel SE, Quinn NP. Multiple system atrophy with Lewy bodies. Rev Neurol (Paris). 1995;151:398-403.
24. Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol. 1961;20:237-244.
25. Kosaka K, Yoshimura M, lkeda K, et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: a new disease? Clin Neuropathol. 1984;3:185-192.
26. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci. 1990;95:119-139.
27. Byrne EJ, Lennox GG, Godwin Austen RB, et al. Dementia associated with cortical Lewy bodies: proposed clinical diagnostic criteria. Dementia. 1991;2:283-284.
28. Hansen LA, Salmon D, Galasko D, et al. Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology. 1990;40:1-8.
29. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology. 1987;37:754-760.
30. Dickson DW, Ruan D, Crystal H, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neuntes specific to DLBD. Neurology. 1991;41:1402-1409.
31. Greenfield JG, Bosanquet FD. The brain-stem lesions in parkinsonism. J Neurol Neurosurg Psychiatry. 1953;16:213-226.
32. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis of parkinsonism: a prospective study. Can J Neurol Sci. 1991;18:275-278.
33. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
34. Jellinger KA, Paulus W. Clinico-pathological correlations in Parkinson's disease. Clin Neurol Neurosurg. 1992;94(suppl):S86-S88.
35. Jellinger KA. Neurodegenerative disorders with extrapyramidal features: a neuropathologic overview. J Neural Transm. 1995;46(suppl):33-57.
36. McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry. 1994; 165:324-332.
37. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology. 1994;44:872-877.
38. Byrne EJ. Cortical Lewy body disease: an alternative view. In: Levy R, Howard R, eds. Developments in Dementia. London, England: Wrightson Biomedical Publishing; 1995:21-30.
39. Mega MS, Masterman DL, Benson F, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology. 1996;47:1403-1409.
40. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44:2015-2019.
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
42. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology. 1996;46:922-930.
43. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathological study. Neurology. 1997;48:119-125.
44. Litvan I, Goetz C, Booth V, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? a clinicopathologic study. Arch Neurol. 1997;54:937-944.
45. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
46. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
47. Galen S, Gambino SR. Beyond Normality: the Predictive Value and Efficiency of Medical Diagnoses. New York, NY: John Wiley & Sons Inc; 1975.
48. JMP Statistics and Graphics Guide. Version 3. Gary, NC: SAS Institute; 1994.
49. Efron B. The Jackknife, the Bootstrap and Other Resampling Plans. Philadelphia, Pa: Society for Industrial and Applied Mathematics; 1982.
50. Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol. 1996;39:37-45.
51. Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA. Diffuse Lewy body disease and progressive dementia. Neurology. 1988;38:1520-1528.
52. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol. 1995;142:820-827.
53. Morgante L, Rocca WA, Di Rosa AE, et al, for The Sicilian Neuro-Epidemiologic Study (SNES) Group. Prevalence of Parkinson's disease and other types of parkinsonism. Neurology. 1992;42:1901-1907.
54. Stacy M, Jankovic J. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes. Neurol Clin. 1992;10:341-359.
55. Litvan I, Agid Y, Caine D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1-9.
56. Louis ED, Klatka LA, Liu Y, Fahn S. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology. 1997;48:376-380.
57. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH, eds. Parkinson's Disease: Anatomy, Pathology and Therapy. Vol 53. New York, NY: Raven Press; 1990:245-249.
58. Koller WC. How accurately can Parkinson's disease be diagnosed? Neurology. 1992;42(suppl 1):6-16.
59. Klatka LA, Louis ED, Schiffer RB. Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology. 1996;47:1148-1152.
60. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51:745-752.
61. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol. 1992;32(suppl):S125-S127.
62. De Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MMB, Maraganore DM. A population perspective on diagnostic criteria for Parkinson's disease. Neurology. 1997;48:1277-1281.
63. Larsen JP, Dupont E, Tandberg E. Clinical diagnosis of Parkinson's disease: proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand. 1994;89:242-251.
64. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease? Neurology. 1992;42:1142-1146.
65. Wenning GK, Tison F, Ben-Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12:133-147.
66. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic criteria. J Neurol Neurosurg Psychiatry. 1995;58:167-173.
67. Daniel SE, De Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain. 1995;118:759-770.
68. Quinn N, Daniel S, Magalhaes-Branco M, Lees A, Hughes A. Lack of pyramidal tract symptoms in Parkinson's disease [letter]. Lancet. 1992;340:125.
69. Wenning GK, Ben-Shlomo Y, Magalhaes-Branco M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain. 1994;117:835-845.
70. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration: a clinical study of 36 cases. Brain. 1994;117:1183-1196.
71. Quinn N. Parkinsonism-recognition and differential diagnosis. BMJ. 1995;310: 447-452.
72. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1996; 60:615-620.
73. Brown RG, Marsden CD. How common is dementia in Parkinson's disease? Lancet. 1984;1:1262-1265.
74. Lieberman A, Dziatolowski M, Coopersmith MEA. Dementia in Parkinson's disease. Ann Neurol. 1979;6:355-359.
75. Lees AJ. Parkinson's disease and dementia. Lancet. 1985;1:43-44.
76. Rajput AH, Offord K, Beard CM, Kurland LT. Epidemiological survey of dementia in parkinsonism and control population. Adv Neurol. 1984;40:229-234.
77. Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? a clinicopathological study. Brain. 1997;120:65-74.
78. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995;58:160-166.
79. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427-442.
80. Robbins TW, James M, Lange KW, Owen AM, Quinn NP, Marsden CD. Cognitive performance in multiple system atrophy. Brain. 1992;115:271-291.
81. Robbins TW, James M, Owen AM, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry. 1994;57:79-88.
82. Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry. 1989;(theme issue):78-89.
83. Quinn N. Multiple system atrophy. In: Marsden C, Fahn S, eds. Movement Disorders 3. Newton, Mass: Butterworth-Heinemann; 1994:262-281.
84. De Bruin VM, Lees AJ, Daniel SE. Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report. Mov Disord. 1992;7:355-358.
85. Fearnley JM, Revesz T, Brooks DJ, Frackowiak RS, Lees AJ. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry. 1991;54:159-161.
86. Rezaie P, Cairns NJ, Chadwick A, Lantos P. Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett. 1996;212: 111-114.
87. Mark MH, Dickson DW, Sage JI, Duvoisin RC. The clinicopathologic spectrum of Lewy body disease. Adv Neurol. 1996;69:315-318.
88. Ala TA, Yang K-H, Sung JH, Frey WH II. Hallucinations and symptoms of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1997;62:16-21.
89. Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn. 1996;31:166-175.
90. Levy R, Eagger S, Griffiths M, et al. Lewy bodies and response to tacrine in Alzheimer's disease. Lancet. 1994;343:176.
91. Del-Ser T, Munoz DG, Hachinski V. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology. 1996;46:682-686.